𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis

✍ Scribed by M. Vukmanovic-Stejic; A. McQuaid; K.E. Birch; J.R. Reed; C. Macgregor; M.H.A. Rustin; A.N. Akbar

Book ID
108668242
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
237 KB
Volume
153
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of human T cell proliferation
Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells
✍ Claire N. Manzotti; Helen Tipping; Laura C. A. Perry; Karen I. Mead; Patrick J. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 263 KB πŸ‘ 2 views

CD28 and CTLA-4 are opposing regulators of T cell activation, triggered by the two ligands CD80 and CD86. How these ligands promote either T cell activation via CD28 or inhibition via CTLA-4 is not understood. Using CD80 and CD86 molecules expressed on transfected cells, we have identified a major d

CD4+CD25+ regulatory T cells in patients
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies : Possible involvement of regulatory T cells in disease progression
✍ Tetsuro Sasada; Motohide Kimura; Yuka Yoshida; Michiyuki Kanai; Arimichi Takabay πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 191 KB

## Abstract ## BACKGROUND Active suppression by CD4^+^CD25^+^ regulatory T cells plays an important role in the down‐regulation of the response of T cells to foreign and self antigens. Experimental tumor models in mice revealed that regulatory T cells inhibit antitumor immune responses. The purpos